1 / 27

Monitoring & Evaluation for Equity & Effectiveness ME3

Monitoring & Evaluation for Equity & Effectiveness ME3. The F1 M & E System. Rationale. The F1 reforms were instituted to help us achieve goals faster and better for the poor.

judah
Télécharger la présentation

Monitoring & Evaluation for Equity & Effectiveness ME3

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Monitoring & Evaluation for Equity & EffectivenessME3 The F1 M & E System

  2. Rationale • The F1 reforms were instituted to help us achieve goals faster and better for the poor • Need to measure progress, not merely on reform strategies, but more on how it has helped us attain the goals and results we want to achieve • Need to provide data to stakeholders for outcomes valuable to the poor and the Filipino people, for which they are accountable for

  3. II. GOAL To establish how reforms have improved outcomes for the poor, and how reforms have equitably and effectively achieved goals in the health systems . • Measuring: • Equity • how reforms have improved outcomes for the poor • Effectiveness • how reforms have achieved goals in the health systems

  4. Purpose • Make available to all stakeholders of F1 relevant data on the health sector’s progress towards attaining improvements in F1 goals • Establish, improve, develop and maintain systems for generating, collecting, reporting, analyzing and using data to enhance attainment of F1 goals

  5. Objectives • Defining Performance Indicators • Establish contribution of stakeholders to outcomes and outputs • Report to clients and stakeholders • To assess F1 policy levers for revision or augmentation

  6. Final Performance Outcomes Financial Risk Protection HEALTH STATUS Responsiveness Intermediate Performance Outcomes Financial Burden Access Quality Efficiency SERVICE DELIVERY Major Final Outputs Financing Regulation Governance Performance Indicator Framework

  7. PIF FINAL OUT-COMES INTERMEDIATEOUT-COMES MFO-LGU MFO-CHD MFO-CO

  8. IV. COMPONENTS OF THE ME3 B. Scorecards and Performance Assessment • A tool for measuring and reporting on performance of stakeholders for outcomes and outputs that can be attributed to them and for which they are accountable for • Measure performance on outcomes valuable to the stakeholders clients and convey performance in a manner that clients and stakeholders can easily comprehend • Serves as Tool for Performance Benchmarks, and for Accountability to clients • Subset of indicators taken from overall PIF

  9. Scorecards • Categories of performance levels • Color Coded: Green, Yellow, Red • Easy Label of Status and Link to Decisions • Challenge: • Selecting 10 Indicators from PIF • That reflect performance • Valuable & Understandable to clients • 10 Themes with 2-3 summated PIs under it

  10. IV. COMPONENTS OF THE ME3 C. Methods for collecting, storing and reporting on results • Population or household surveys, facility surveys, routine records and reports in the health system, special studies, etc. shall be utilized • Additional data sources shall be established • Data banking and reporting shall also be developed

  11. IV. COMPONENTS OF THE ME3 D. Baseline studies and parallel scorecards • A baseline study shall be done utilizing indicators and assigned data source developed (2007 Q1) • The baseline study shall provide information on 1) status of performance of the health system, particularly for incoming Local Chief Executives 2) areas of the PIF that need to be improved or revised 3) targets that need to be revised or set

  12. IV. COMPONENTS OF THE ME3 E. System of governance of the F1 ME3 • Governance system shall be established which shall cover concerns such as level of independence of the ME3, internal rules, decision making process

  13. DOH CLUSTERS TWGs (development of F1 ME3) VI. Functional Structure DOH EXECOM (Policy decisions) TCG (Technical Approval) DOH Task Force on F1 M&E (Coordination and Guiding Work)

  14. Cluster TWGs

  15. Technical Exchange FellowsUSAID

  16. ME3 IMPLEMENTATION

  17. Implementation Structure DOH EXECOM (Policy decisions) FICOs, PSDOs, SMCO, SMCT TCG (Technical Approval) HPDPB MIS LEVELS OF STAKEHOLDERS LEVELS OF STAKEHOLDERS LEVELS OF STAKEHOLDERS LEVELS OF STAKEHOLDERS LEVELS OF STAKEHOLDERS

  18. IV. COMPONENTS OF THE ME3 F. Capability Building • Competent units and personnel • IT and MIS systems • Funds for surveys and special studies

  19. V. Phases of Activities and Timelines

  20. Draft PIF & Scorecards Consultations Pretest Baseline Survey TASKS • Final Outcomes • Intermediate Outcomes • Major Final Outputs • Select key Indicators for Scorecard • Small Groups • E-Mail • National Consultation(Dec.4-5) For Feasibility Q1 2007

  21. Central government  regional offices Local government Family/individual Health outcome Provider Supplier

  22. DOH HOSPITALS LGU PSD-SD SMCO IMCO CHD NCDPC HPDPB Finance PROVIDER (Public & Private NCHFD BIHC Procurement NCHP BLHD MIS CLIENT NEC HHRDB MDG-F1 Linkage Infant & Child Mortality Rate Pneumonia Mortality Rate Diarrhea Mortality Rate Malnutriton Rate Water & Sanitation B. Sepsis Mortality Rate ACCESS QUALITY FINANCIAL IMPACT EFFICIENCY

  23. LGU Scorecard Framework FINAL OUTCOME Health MDGs Intermediate Outcome Intermediate Outcomes Clients Actions/Decisions Providers/Staff Actions/Decisions Inputs Outputs Client Characteristics Facility Characteristics LGU Actions/Decisions

  24. Implementation Schedule

More Related